Variation in Inflammatory Cytokine/Growth-Factor Genes and Mammographic Density in Premenopausal Women Aged 50-55

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Ozhand, Ali ^a   Lee, Eunjung ^a   Wu, Anna H ^a   Ellingjord Dale, Merete ^b   Akslen, Lars A ^c   McKean Cowdin, Roberta ^a   Ursin, Giske ^a,b,d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d CANCER REGISTRY OF NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2; INTERLEUKIN 6; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ADULT; ALLELE; ARTICLE; CHINESE; FEMALE; FIBROBLAST GROWTH FACTOR RECEPTOR 2 GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; INTERLEUKIN 6 GENE; MAMMOGRAPHIC DENSITY; PREMENOPAUSE; RADIOLOGICAL PARAMETERS; RISK FACTOR; SINGAPORE; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATOMEDIN BINDING PROTEIN 1 GENE; SOMATOMEDIN BINDING PROTEIN 3 GENE; TRANSFORMING GROWTH FACTOR BETA1 GENE; TUMOR NECROSIS FACTOR GENE; VASCULOTROPIN GENE;

ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; BREAST NEOPLASMS; CYTOKINES; EARLY DETECTION OF CANCER; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; HUMANS; INFLAMMATION MEDIATORS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-6; MAMMARY GLANDS, HUMAN; MIDDLE AGED; NORWAY; POLYMORPHISM, SINGLE NUCLEOTIDE; PREMENOPAUSE; SINGAPORE;

EID: 84878758658     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065313     Document Type: Article

References (55)

1. Boyd N, Lockwood G, Martin L, Knight J, Byng J, et al. (1998) Mammographic densities and breast cancer risk. Breast Dis 10: 113-126.
2. Boyd N, Guo H, Martin L, Sun L, Stone J, et al. (2007) Mammographic density and the risk and detection of breast cancer. N Engl J Med 356: 227-236.
3. McCormack V, dos Santos Silva I, (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15: 1159-1169.
4. Vachon C, Kuni C, Anderson K, Anderson V, Sellers T, (2000) Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control 11: 653-662.
5. Boyd N, Dite G, Stone J, Gunasekara A, English D, et al. (2002) Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 347: 886-894.
6. Ursin G, Lillie E, Lee E, Cockburn M, Schork N, et al. (2009) The relative importance of genetics and environment on mammographic density. Cancer Epidemiol Biomarkers Prev 18: 102-112.
7. Stone J, Gurrin L, Byrnes G, Schroen C, Treloar S, et al. (2007) Mammographic density and candidate gene variants: a twins and sisters study. Cancer Epidemiol Biomarkers Prev 16: 1479-1484.
8. Lindstrom S, Vachon CM, Li J, Varghese J, Thompson D, et al. (2011) Common variants in ZNF365 are associated with both mammographic density and breast cancer risk. Nat Genet 43: 185-187.
9. Fletcher O, Johnson N, Orr N, Hosking FJ, Gibson LJ, et al. (2011) Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. J Natl Cancer Inst 103: 425-435.
10. Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, et al. (2009) Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 41: 585-590.
11. Hawes D, Downey S, Pearce CL, Bartow S, Wan P, et al. (2006) Dense breast stromal tissue shows greatly increased concentration of breast epithelium but no increase in its proliferative activity. Breast Cancer Res 8: R24.
12. Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ, (1998) Mammographic densities and breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention 7: 1133-1144.
13. Guo Y, Martin L, Hanna W, Banerjee D, Miller N, et al. (2001) Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev 10: 243-248.
14. Alowami S, Troup S, Al-Haddad S, Kirkpatrick I, Watson PH, (2003) Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res 5: R129-135.
15. Cullen KJ, Lippman ME, (1992) Stromal-epithelial interactions in breast cancer. Cancer Treat Res 61: 413-431.
16. Sakakura T, (1991) New aspects of stroma-parenchyma relations in mammary gland differentiation. Int Rev Cytol 125: 165-202.
17. Dickson RB, Lippman ME, (1995) Growth factors in breast cancer. Endocr Rev 16: 559-589.
18. Sternlicht MD, (2006) Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis. Breast Cancer Res 8: 201.
19. Streuli CH, Akhtar N, (2009) Signal co-operation between integrins and other receptor systems. Biochem J 418: 491-506.
20. Kadler KE, Hill A, Canty-Laird EG, (2008) Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators. Curr Opin Cell Biol 20: 495-501.
21. Kass L, Erler JT, Dembo M, Weaver VM, (2007) Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis. Int J Biochem Cell Biol 39: 1987-1994.
22. Bremnes Y, Ursin G, Bjurstam N, Rinaldi S, Kaaks R, et al. (2007) Insulin-like growth factor and mammographic density in postmenopausal Norwegian women. Cancer Epidemiol Biomarkers Prev 16: 57-62.
23. dos Santos Silva I, Johnson N, De Stavola B, Torres-Mejía G, Fletcher O, et al. (2006) The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prev 15: 449-455.
24. Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, et al. (2000) Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 60: 3744-3748.
25. Boyd NF, Stone J, Martin LJ, Jong R, Fishell E, et al. (2002) The association of breast mitogens with mammographic densities. Br J Cancer 87: 876-882.
26. Diorio C, Pollak M, Byrne C, Mâsse B, Hébert-Croteau N, et al. (2005) Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev 14: 1065-1073.
27. Tamimi R, Cox D, Kraft P, Pollak M, Haiman C, et al. (2007) Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study. Breast Cancer Res 9: R18.
28. Biong M, Gram I, Brill I, Johansen F, Solvang H, et al. (2010) Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density. BMC Med Genomics 3: 9.
29. Verheus M, McKay JD, Kaaks R, Canzian F, Biessy C, et al. (2008) Common genetic variation in the IGF-1 gene, serum IGF-I levels and breast density. Breast Cancer Res Treat 112: 109-122.
30. Verheus M, Maskarinec G, Woolcott C, Haiman C, Le Marchand L, et al. (2010) IGF1, IGFBP1, and IGFBP3 genes and mammographic density: the Multiethnic Cohort. Int J Cancer 127: 1115-1123.
31. Yang WT, Lewis MT, Hess K, Wong H, Tsimelzon A, et al. (2010) Decreased TGFbeta signaling and increased COX2 expression in high risk women with increased mammographic breast density. Breast Cancer Res Treat 119: 305-314.
32. Reeves KW, Weissfeld JL, Modugno F, Diergaarde B (2010) Circulating levels of inflammatory markers and mammographic density among postmenopausal women. Breast Cancer Res Treat.
33. Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, et al. (2003) Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 95: 30-37.
34. McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, et al. (2005) Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial. J Natl Cancer Inst 97: 1366-1376.
35. Ellingjord-Dale M, Lee E, Couto E, Ozhand A, Qureshi SA, et al. (2012) Polymorphisms in hormone metabolism and growth factor genes and mammographic density in Norwegian postmenopausal hormone therapy users and non-users. Breast Cancer Res 14: R135.
36. Hofvind S, Geller B, Vacek PM, Thoresen S, Skaane P, (2007) Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program. Eur J Epidemiol 22: 447-455.
37. Qureshi SA, Couto E, Hilsen M, Hofvind S, Wu AH, et al. (2011) Mammographic density and intake of selected nutrients and vitamins in Norwegian women. Nutr Cancer 63: 1011-1020.
38. Ursin G, Ma H, Wu A, Bernstein L, Salane M, et al. (2003) Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 12: 332-338.
39. Edlund C, Lee W, Li D, Van Den Berg D, Conti D, (2008) Snagger: a user-friendly program for incorporating additional information for tagSNP selection. BMC Bioinformatics 9: 174.
40. Kleinbaum DG, Nizam A, Muller KE (2007) Applied Regression Analysis and Other Multivariable Methods: Duxbury Press.
41. Wu AH, Ursin G, Koh WP, Wang R, Yuan JM, et al. (2008) Green tea, soy, and mammographic density in Singapore Chinese women. Cancer Epidemiol Biomarkers Prev 17: 3358-3365.
42. Lee E, Hsu C, Van den Berg D, Ursin G, Koh WP, et al. (2012) Genetic variation in peroxisome proliferator-activated receptor gamma, soy, and mammographic density in singapore chinese women. Cancer Epidemiol Biomarkers Prev 21: 635-644.
43. Ng EH, Ng FC, Tan PH, Low SC, Chiang G, et al. (1998) Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project. Cancer 82: 1521-1528.
44. Jakes RW, Duffy SW, Ng FC, Gao F, Ng EH, et al. (2002) Mammographic parenchymal patterns and self-reported soy intake in Singapore Chinese women. Cancer Epidemiol Biomarkers Prev 11: 608-613.
45. Ursin G, Sun CL, Koh WP, Khoo KS, Gao F, et al. (2006) Associations between soy, diet, reproductive factors, and mammographic density in Singapore Chinese women. Nutr Cancer 56: 128-135.
46. Boyd N, Byng J, Jong R, Fishell E, Little L, et al. (1995) Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87: 670-675.
47. Taverne CW, Verheus M, McKay JD, Kaaks R, Canzian F, et al. (2010) Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density. Breast Cancer Res Treat 123: 843-855.
48. Lee E, Haiman CA, Ma H, Van Den Berg D, Bernstein L, et al. (2008) The role of established breast cancer susceptibility loci in mammographic density in young women. Cancer Epidemiol Biomarkers Prev 17: 258-260.
49. Woolcott CG, Maskarinec G, Haiman CA, Verheus M, Pagano IS, et al. (2009) Association between breast cancer susceptibility loci and mammographic density: the Multiethnic Cohort. Breast Cancer Res 11: R10.
50. Mulhall C, Hegele RA, Cao H, Tritchler D, Yaffe M, et al. (2005) Pituitary growth hormone and growth hormone-releasing hormone receptor genes and associations with mammographic measures and serum growth hormone. Cancer Epidemiol Biomarkers Prev 14: 2648-2654.
51. Basolo F, Conaldi P, Fiore L, Calvo S, Toniolo A, (1993) Normal breast epithelial cells produce interleukins 6 and 8 together with tumor-necrosis factor: defective IL6 expression in mammary carcinoma. Int J Cancer 55: 926-930.
52. Knüpfer H, Preiss R, (2007) Significance of interleukin-6 (IL-6) in breast cancer (review). Breast Cancer Res Treat 102: 129-135.
53. Purohit A, Newman SP, Reed MJ, (2002) The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer. Breast Cancer Res 4: 65-69.
54. Andersson N, Strandberg L, Nilsson S, Adamovic S, Karlsson M, et al. (2010) A variant near the interleukin-6 gene is associated with fat mass in Caucasian men. Int J Obes (Lond) 34: 1011-1019.
55. Zhang X, Liu RY, Lei Z, Zhu Y, Huang JA, et al. (2009) Genetic variants in interleukin-6 modified risk of obstructive sleep apnea syndrome. Int J Mol Med 23: 485-493.